# Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

> **NCT04184869** · PHASE1 · COMPLETED · sponsor: **Acrotech Biopharma Inc.** · enrollment: 8 (actual)

## Conditions studied

- Solid Tumor
- Hematological Malignancies

## Interventions

- **DRUG:** Belinostat
- **DRUG:** Atazanavir

## Key facts

- **NCT ID:** NCT04184869
- **Lead sponsor:** Acrotech Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-05
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04184869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04184869, "Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04184869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*